About Bruker
Bruker is a company based in United States founded in 1960. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 11,400 employees as of December 31, 2024. Bruker has completed 43 acquisitions, including ACQUIFER, Active Spectrum and Acuity Spatial Genomics. Bruker offers products and services including Hysitron PI Envision SEM PicoIndenter, MOVE-T Liquid Dairy Analyzer, S8 TIGER Series 3, and nVista 2P System. Bruker operates in a competitive market with competitors including Cepheid, Beckman Coulter, Blackrock Neurotech, Esco Lifesciences and Agilent, among others.
- Headquarter United States
- Employees 11400 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bruker Corporation
-
Annual Revenue
$3.37 B (USD)13.56as on Dec 31, 2024
-
Net Profit
$113.1 M (USD)-73.53as on Dec 31, 2024
-
EBITDA
$563.6 M (USD)-5.63as on Dec 31, 2024
-
Latest Funding Round
$112.71 K (USD), Grant
Nov 17, 2022
-
Investors
HHS
& 6 more
-
Employee Count
11400
as on Dec 31, 2024
-
Investments & Acquisitions
ACQUIFER
& 42 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bruker
Bruker is a publicly listed company on the NASDAQ with ticker symbol BRKR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bruker
Bruker offers a comprehensive portfolio of products and services, including Hysitron PI Envision SEM PicoIndenter, MOVE-T Liquid Dairy Analyzer, S8 TIGER Series 3, and nVista 2P System.
In-situ SEM nanoindentation system is used for testing.
Compact FT-NIR analyzer is used for dairy analysis.
Versatile tool is used for elemental industry analysis.
Two-photon miniscope is used for neural circuit imaging.
People of Bruker
Unlock access to complete
Unlock access to complete
Software Development Team
43 people
Leadership Team
37 people
Finance and Accounting
29 people
Sales and Marketing
29 people
Legal and Compliance
13 people
Field Team
11 people
Senior Team
10 people
Accounts Team
8 people
Unlock access to complete
Funding Insights of Bruker
Investors in Bruker
Bruker has secured backing from 7 investors, including institutional investors. Prominent investors backing the company include HHS, European Commission and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Institution of the European Union responsible for upholding the EU treaties
|
Locked | Locked | Locked | |
|
Wealth management services are provided to high-net-worth clients.
|
Locked | Locked | Locked |
Investor details for Bruker
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bruker
Bruker has strategically engaged in corporate development activities, having acquired 43 companies. Notable acquisitions include ACQUIFER, Active Spectrum and Acuity Spatial Genomics.
Investment portfolio details for Bruker
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Optofluidic systems are designed and manufactured by PhenomeX.
|
Locked | Locked | 2023 | Locked | |
|
A 3D genomics platform is developed for multi-omic analyses.
|
Locked | Locked | 2020 | Locked | |
|
Cell line engineering services are offered via CRISPR-Cas9 technology.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Bruker
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bruker
Detailed financials for Bruker
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bruker Comparisons
Peer comparison for Bruker
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bruker
Bruker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Blackrock Neurotech, Esco Lifesciences and Agilent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Diversified instruments are developed for scientific and laboratory management.
|
Detailed competitors of Bruker
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bruker
Complete news archive for Bruker
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bruker
Bruker was founded in 1960 and raised its 1st funding round 41 years after it was founded.
Bruker is headquartered in United States.
As of Dec 31, 2024, the latest employee count at Bruker is 11,400.
Annual revenue of Bruker is $3.37B as on Dec 31, 2024.
Innovative life science research and diagnostics solutions are delivered by Bruker. Focus is placed on spatial biology, single-cell analysis, and biopharma applications. Advanced instruments like NMR spectrometers and SEM nanoindentation systems are offered. Support is extended to academia and industry for scientific advancements. Services ensure maximized uptime and productivity for customers. Sectors such as healthcare, technology, and materials research are covered.
Bruker's top competitors include Cepheid, Blackrock Neurotech and Agilent.
Bruker offers Hysitron PI Envision SEM PicoIndenter, MOVE-T Liquid Dairy Analyzer, S8 TIGER Series 3, and nVista 2P System.
Yes, Bruker is publicly traded on NASDAQ under the ticker symbol BRKR.
Bruker has made 43 acquisitions, including ACQUIFER, Active Spectrum, and Acuity Spatial Genomics.
Bruker has 7 investors. Key investors include HHS, European Commission, European Union, Burrill and Company, and Thomas Weisel Partners.
The ticker symbol of Bruker is BRKR on NASDAQ.